Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$0.56 - $1.41 $42,560 - $107,160
-76,000 Reduced 73.66%
27,170 $35,000
Q4 2023

Feb 07, 2024

SELL
$0.57 - $0.85 $4,845 - $7,225
-8,500 Reduced 7.61%
103,170 $58,000
Q3 2023

Nov 14, 2023

BUY
$0.69 - $0.85 $77,052 - $94,919
111,670 New
111,670 $83,000
Q1 2023

May 12, 2023

SELL
$0.71 - $1.25 $6,390 - $11,250
-9,000 Reduced 7.63%
108,970 $82,000
Q4 2022

Feb 01, 2023

SELL
$0.75 - $2.24 $19,035 - $56,851
-25,380 Reduced 17.7%
117,970 $113,000
Q3 2022

Mar 14, 2023

BUY
$2.09 - $4.5 $20,482 - $44,100
9,800 Added 7.34%
143,350 $312,000
Q3 2022

Nov 07, 2022

BUY
$2.09 - $4.5 $20,482 - $44,100
9,800 Added 7.34%
143,350 $313,000
Q2 2022

Mar 14, 2023

SELL
$2.7 - $5.28 $72,900 - $142,560
-27,000 Reduced 16.82%
133,550 $467,000
Q2 2022

Aug 02, 2022

SELL
$2.7 - $5.28 $72,900 - $142,560
-27,000 Reduced 16.82%
133,550 $467,000
Q1 2022

Mar 14, 2023

BUY
$4.29 - $6.64 $3,003 - $4,648
700 Added 0.44%
160,550 $809,000
Q1 2022

May 12, 2022

BUY
$4.29 - $6.64 $3,003 - $4,648
700 Added 0.44%
160,550 $809,000
Q4 2021

Mar 14, 2023

BUY
$5.77 - $7.96 $200,969 - $277,246
34,830 Added 27.86%
159,850 $1 Million
Q4 2021

Feb 14, 2022

BUY
$5.77 - $7.96 $200,969 - $277,246
34,830 Added 27.86%
159,850 $1 Million
Q3 2021

Mar 14, 2023

BUY
$6.67 - $9.8 $96,181 - $141,316
14,420 Added 13.04%
125,020 $993,000
Q3 2021

Nov 04, 2021

BUY
$6.67 - $9.8 $96,181 - $141,316
14,420 Added 13.04%
125,020 $994,000
Q2 2021

Mar 14, 2023

BUY
$5.06 - $10.78 $252,999 - $539,000
50,000 Added 82.51%
110,600 $828,000
Q2 2021

Aug 11, 2021

BUY
$5.06 - $10.78 $252,999 - $539,000
50,000 Added 82.51%
110,600 $828,000
Q1 2021

Mar 14, 2023

BUY
$5.64 - $23.33 $168,072 - $695,234
29,800 Added 96.75%
60,600 $366,000
Q1 2021

May 17, 2021

BUY
$5.64 - $23.33 $168,072 - $695,234
29,800 Added 96.75%
60,600 $367,000
Q4 2020

Mar 14, 2023

BUY
$3.5 - $7.98 $42,350 - $96,558
12,100 Added 64.71%
30,800 $175,000
Q4 2020

Feb 16, 2021

BUY
$3.5 - $7.98 $42,350 - $96,558
12,100 Added 64.71%
30,800 $176,000
Q3 2020

Mar 14, 2023

SELL
$4.78 - $16.97 $474,510 - $1.68 Million
-99,270 Reduced 84.15%
18,700 $124,000
Q3 2020

Nov 16, 2020

BUY
$4.78 - $16.97 $89,386 - $317,339
18,700 New
18,700 $124,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $86M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Private Portfolio Partners LLC Portfolio

Follow Private Portfolio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.